OptiBiotix Health has the GF Score of 39, which implies that the company
might have
Worst future performance potential, or not enough data.
The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.
GF Score takes following five key aspects into consideration:
Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.
Based on research and backtesting result, GuruFocus believes OptiBiotix Health
might have
Worst future performance potential, or not enough data.
Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.
OptiBiotix Health (OTCPK:OPTBF) GF Score Explanation
Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:
GF Score
Performance Potential and All-in-One Screener Examples (1)
(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.
OptiBiotix Health GF Score Related Terms
OPTBF vs VRTX, REGN, ALNY: GF Score Comparison
For the Biotechnology subindustry, OptiBiotix Health's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
OptiBiotix Health GF Score vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, OptiBiotix Health's GF Score distribution charts can be found below:
* The bar in red indicates where OptiBiotix Health's GF Score falls into.
OptiBiotix Health (OPTBF) has a GF Score of 39 as of Jul. 11, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on OptiBiotix Health and its competitors. This is near median its historical median of 38.00. Over the past decade, OptiBiotix Health's GF Score has ranged from 14.00 to 53.00.
Is OptiBiotix Health's GF Score too high?
OptiBiotix Health's current GF Score of 39 is near median its 10-year median of 38.00. Over the past 10 years, this metric has ranged from a low of 14.00 to a high of 53.00. Overall, OptiBiotix Health has a GF Score™ of 39/100, reflecting its overall financial health beyond just this single metric.
How does OptiBiotix Health's GF Score compare to VRTX and REGN?
OptiBiotix Health's GF Score of 39 can be compared against companies in the Biotechnology industry. Historically, OptiBiotix Health's own GF Score has ranged from 14.00 to 53.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Biotechnology company?
A good GF Score depends on the Biotechnology industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on OptiBiotix Health and its competitors. OptiBiotix Health's current GF Score is 39, which is near median its own 10-year median of 38.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OptiBiotix Health stock overvalued right now?
OptiBiotix Health (OPTBF) has a current GF Score of 39. The stock's GF Value™ is $0.51, compared to a current price of $0.11 — trading 78.4% below its estimated fair value. The current GF Score is 39, which is near median its 10-year median of 38.00. OptiBiotix Health's overall GF Score™ is 39/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For OptiBiotix Health (OPTBF), the current GF Score is 39 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is OptiBiotix Health (OPTBF) Overvalued in 2026?
Based on GuruFocus' analysis, OptiBiotix Health stock appears to be undervalued.
The current stock price of $0.11 is trading 78.4% below its estimated GF Value™ of $0.51.
Key valuation signals for OPTBF:
GF Score: 39 (near median its 10-year median of 38.00)
GF Value™: $0.51 vs. price of $0.11 (78.4% below fair value)
No single metric tells the full story. See the OPTBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
OptiBiotix Health PLC principal activity is that of identifying and developing microbial strains, compounds, and formulations for use in food ingredients, supplements and active compounds that can impact on human physiology, deriving potential health benefits. It is a life sciences business focused on the development of products which reduce hunger and food cravings, enhance the gut microbiome, and provide a healthy substitute for sugar. Its product portfolio includes First-generation products- SlimBiome, WellBiome; and Second-generation solutions- SweetBiotix, Microbiome Modulators. The group has one class of business. It has presence in United Kingdom, United States, India China, and Rest of world. The company generates majority of revenue from United States.
39GF Score
Get the complete analysis for OPTBF
GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OPTBF has been successfully added to your 